Dr. Bal brings over 20 years of experience spanning corporate strategy, management consulting, operations, investment banking and R&D across pharma, biotech, healthcare and health-tech industries. He played lead roles in organizations such as Booz Allen Hamilton, Dana-Farber/Harvard Cancer Center, Takeda Oncology, Astellas Pharma and Cold Spring Harbor Laboratory; and is a subject matter expert in immuno-oncology, infectious disease, cardiovascular and metabolic therapy, covering small and large molecules and gene therapies.
Dr. Bal brings leadership experience, working with Boards and CEOs to facilitate alliances and partnerships with small and large corporations, including capital raising and cross-border M&A transactions, along with an extensive network in the life sciences and investor community across North America, Europe, UK, Japan and India. He previously headed global strategy and business development for a biopharma R&D company, managing global biopharma, specialty and Fortune 500 clients to advance clinical development pipelines from IND and NDA to launch and commercialization.
Dr. Bal holds a Ph.D. in Molecular Biology from the National Institute of Immunology, New Delhi and is a graduate of the Executive General Management Program of The Wharton School of the University of Pennsylvania.